LOCAMETZ

kit for the preparation of gallium-68 gozetotide · Advanced Accelerator Applications USA, Inc

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for LOCAMETZ, covering 2022-03-23 to 2026-07-09. Get the full timeline:

Most recent: EMA Authorised: Locametz (gozetotide) — Novartis Europharm Limited